Text Size
29 studies found for:    " February 29, 2012":" March 30, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Fetal HIV Transmission Risk and Duration of Membrane Rupture
Conditions: Human Immunodeficiency Virus;   HIV
Intervention:
2 Active, not recruiting Safety and Efficacy of Darunavir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Cobicistat-boosted Darunavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed Dose Combination in HIV-1 Infected, Antiretroviral Treatment Naive Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: darunavir/cobicistat/emtricitabine/GS-7340;   Drug: darunavir + cobicistat + emtricitabine/tenofovir df
3 Recruiting Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Conditions: HIV;   AIDS;   Substance Abuse
Intervention: Behavioral: Retention Clinic
4 Recruiting Assessing the Safety of Dapivirine Gel and Film Formulations
Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Film;   Drug: Dapivirine Vaginal Gel
5 Recruiting Mild Neurocognitive Disorder in HIV Infection of the Brain
Condition: HIV-Associated Cognitive Motor Complex
Intervention:
6 Active, not recruiting Phase I/IIa Dose-escalation Clinical Study of VAC-3S
Condition: HIV-1 Infection
Interventions: Biological: VAC-3S;   Biological: Placebo
7 Active, not recruiting Part A: Drug Interaction Study of GS-7977 and Antiretroviral Therapy(ART) Combinations in Human Immunodeficiency Virus and Hepatitis C Virus (HIV/HCV) Co-infected Patients. Part B: Phase 2, Open-Label Study to Investigate Efficacy and Safety of GS-7977 for 12 Weeks in HIV/HCV Co-infected Patients.
Conditions: Hepatitis C;   HIV
Interventions: Drug: GS-7977;   Drug: Efavirenz (EFV);   Drug: Tenofovir (TDF);   Drug: Emtricitabine (FTC);   Drug: Atazanavir/ritonavir (ATV/r);   Drug: Zidovudine (ZDV);   Drug: Lamivudine (3TC);   Drug: Darunavir/ritonavir (DRV/r);   Drug: Raltegravir (RAL);   Drug: Ribavirin (RBV);   Drug: Peginterferon Alfa 2a (PEG)
8 Unknown † Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
Conditions: To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT;   To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
Interventions: Radiation: Radiation therapy;   Other: Venepuncture
9 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Intervention: Biological: VRC-HIVADV014-00-VP Vaccine
10 Completed Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA009-00-VP;   Biological: Placebo vaccine
11 Completed Sevelamer for Reducing Endotoxemia and Immune Activation
Condition: HIV-1 Infection
Interventions: Drug: Sevelamer carbonate;   Device: Sevelamer carbonate
12 Recruiting Improving Blood Safety and HIV Testing in Brazil
Conditions: HIV;   Herpes Simplex 2;   Hepatitis C;   Hepatitis B;   Chagas Disease
Interventions: Behavioral: HIV Counseling and Testing;   Behavioral: Blood Donation
13 Completed A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG;   Drug: BCV;   Drug: TVR
14 Active, not recruiting Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg twice daily;   Drug: dolutegravir placebo twice daily;   Drug: Open-label dolutegravir 50mg twice daily
15 Recruiting Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men
Conditions: HIV;   Patient Compliance
Interventions: Behavioral: Positive Choices;   Behavioral: Personalized Cognitive Counseling
16 Recruiting Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Condition: HIV
Intervention: Genetic: SB-728-T
17 Active, not recruiting Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya
Conditions: HIV;   Malnutrition
Intervention: Other: Multi-sectoral agricultural intervention
18 Recruiting A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
Condition: HIV-associated Myelopathy
Interventions: Drug: Intravenous Immunoglobulin;   Drug: Placebo
19 Recruiting The Rilpivirine Cerebrospinal-fluid (CSF) Study
Condition: HIV
Intervention: Drug: Rilpivirine
20 Recruiting A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally
Condition: HIV Prevention
Interventions: Drug: Rectal formulation (RF) of tenofovir 1% gel;   Drug: Vaginal formulations (original VF and reduced vaginal glycerin formulation RGVF) of tenofovir 1% gel;   Drug: Universal HEC Placebo Gel Formulation
To Top

Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results
† Indicates status has not been verified in more than two years